GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sipai Health Technology Co Ltd (FRA:AX1) » Definitions » Beneish M-Score

Sipai Health Technology Co (FRA:AX1) Beneish M-Score : -2.00 (As of May. 05, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Sipai Health Technology Co Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Sipai Health Technology Co's Beneish M-Score or its related term are showing as below:

FRA:AX1' s Beneish M-Score Range Over the Past 10 Years
Min: -2   Med: -2   Max: -2
Current: -2

During the past 3 years, the highest Beneish M-Score of Sipai Health Technology Co was -2.00. The lowest was -2.00. And the median was -2.00.


Sipai Health Technology Co Beneish M-Score Historical Data

The historical data trend for Sipai Health Technology Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sipai Health Technology Co Beneish M-Score Chart

Sipai Health Technology Co Annual Data
Trend Dec21 Dec22 Dec23
Beneish M-Score
- - -2.00

Sipai Health Technology Co Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Beneish M-Score - - - - -2.00

Competitive Comparison of Sipai Health Technology Co's Beneish M-Score

For the Medical Distribution subindustry, Sipai Health Technology Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sipai Health Technology Co's Beneish M-Score Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sipai Health Technology Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Sipai Health Technology Co's Beneish M-Score falls into.



Sipai Health Technology Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Sipai Health Technology Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.17+0.528 * 0.9305+0.404 * 2.0867+0.892 * 1.0849+0.115 * 0.9046
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.6164+4.679 * -0.043438-0.327 * 1.1236
=-2.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was €74.1 Mil.
Revenue was €605.2 Mil.
Gross Profit was €53.3 Mil.
Total Current Assets was €313.7 Mil.
Total Assets was €361.5 Mil.
Property, Plant and Equipment(Net PPE) was €10.4 Mil.
Depreciation, Depletion and Amortization(DDA) was €6.8 Mil.
Selling, General, & Admin. Expense(SGA) was €82.2 Mil.
Total Current Liabilities was €146.7 Mil.
Long-Term Debt & Capital Lease Obligation was €5.1 Mil.
Net Income was €-32.8 Mil.
Gross Profit was €0.0 Mil.
Cash Flow from Operations was €-17.1 Mil.
Total Receivables was €58.4 Mil.
Revenue was €557.8 Mil.
Gross Profit was €45.7 Mil.
Total Current Assets was €365.0 Mil.
Total Assets was €396.7 Mil.
Property, Plant and Equipment(Net PPE) was €12.0 Mil.
Depreciation, Depletion and Amortization(DDA) was €6.7 Mil.
Selling, General, & Admin. Expense(SGA) was €122.9 Mil.
Total Current Liabilities was €142.9 Mil.
Long-Term Debt & Capital Lease Obligation was €5.2 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(74.107 / 605.165) / (58.381 / 557.796)
=0.122458 / 0.104664
=1.17

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(45.679 / 557.796) / (53.259 / 605.165)
=0.081892 / 0.088007
=0.9305

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (313.682 + 10.416) / 361.529) / (1 - (364.961 + 12.032) / 396.675)
=0.103535 / 0.049617
=2.0867

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=605.165 / 557.796
=1.0849

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(6.692 / (6.692 + 12.032)) / (6.803 / (6.803 + 10.416))
=0.357402 / 0.395087
=0.9046

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(82.208 / 605.165) / (122.929 / 557.796)
=0.135844 / 0.220383
=0.6164

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((5.052 + 146.656) / 361.529) / ((5.246 + 142.898) / 396.675)
=0.419629 / 0.373464
=1.1236

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-32.848 - 0 - -17.144) / 361.529
=-0.043438

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Sipai Health Technology Co has a M-score of -2.03 suggests that the company is unlikely to be a manipulator.


Sipai Health Technology Co Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Sipai Health Technology Co's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Sipai Health Technology Co (FRA:AX1) Business Description

Traded in Other Exchanges
Address
No. 1888, Caoyang Road, 7/F, Building 3, Xingguangyao Plaza, Putuo District, Shanghai, CHN
Sipai Health Technology Co Ltd is a medical technology and health management company in China. It has three reportable operating segments: Specialty Pharmacy Business - operation and distribution of specialty pharmacy stores and pharmaceutical products; Physician Research Assistance Business - offering pharmaceutical companies and other clinical trial institutions site management organization services; Health Insurance Services Business - rendering insurance brokerage services to insurance companies. The company generates key revenue from Specialty Pharmacy Business. Almost all of the company's revenues were derived from operations in the PRC.

Sipai Health Technology Co (FRA:AX1) Headlines

No Headlines